I am a drug development professional with >20 years of industry experience. I currently support pharmaceutical companies with drug development efforts as a fully integrated member of the team. Prior to my full-time consulting work, I was Head of Early Clinical Development at Schrödinger where I successfully established clinical sciences, regulatory sciences, clinical operations, GCP quality, pharmacovigilance, and data sciences. Under my leadership, the clinical team filed two successful INDs and CTAs in oncology indications. I successfully advanced the company’s first two global oncology trials and an ex-US healthy volunteer trial into the clinic. In addition, I supported the clinical launch of other oncology assets in the pipeline.

Key areas of expertise include establishing and leading clinical development teams (science, regulatory, operations and quality), setting scientific strategy for early clinical drug development (including first-in-human and proof-of-concept studies), developing target product profiles (TPPs), creating integrated development plans (IDPs/CDPs), successfully submitting investigational new drug applications (INDs), KOL interactions, CRO oversight and medical monitoring of clinical studies. In my most recent role, I successfully transformed a preclinical biotech into a clinical organization through infrastructure build, strategy implementation, and operational excellence.